Which hedge funds own ZNTL? ZENTALIS PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
5 of the hedge funds tracked by WhaleCreep disclosed a position in ZNTL (ZENTALIS PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $27.7m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.0% of its book. 4 exited: Brevan Howard Capital Management, Point72 Asset Management LP, Tudor Investment.
5tracked managers holding
0opened this quarter
4exited this quarter
Which hedge funds hold ZNTL? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $7.8m | 1,609,078 | -17% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $11.1m | 2,298,403 | 33% | added |
| Marshall Wace | Q2 2026 | 0.0% | $2.9m | 591,473 | 51% | added |
| Millennium Management | Q2 2026 | 0.0% | $3.2m | 664,281 | -48% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $2.7m | 546,566 | -63% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $110.1k |
| Point72 Asset Management LP | 0.0% | $222.0k |
| Tudor Investment | 0.0% | $81.5k |
| Woodline Partners | 0.0% | $622.5k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Tybourne Capital Management | Q3 2025 | 4.7% |
How has hedge fund ownership of ZNTL changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 5 | $27.7m |
| Q1 2026 | 9 | $17.0m |
| Q4 2025 | 4 | $4.8m |
| Q3 2025 | 4 | $5.8m |
| Q2 2025 | 4 | $4.1m |
| Q1 2025 | 4 | $3.7m |
| Q4 2024 | 4 | $6.3m |
| Q3 2024 | 4 | $9.6m |
| Q2 2024 | 3 | $12.8m |
| Q1 2024 | 4 | $42.5m |
| Q4 2023 | 3 | $40.5m |
| Q3 2023 | 5 | $87.9m |
| Q2 2023 | 4 | $129.8m |
| Q1 2023 | 4 | $116.3m |
| Q4 2022 | 4 | $152.0m |
| Q3 2022 | 3 | $148.3m |
Counts every tracked manager that disclosed ZNTL in that quarter's filing, including managers that have since stopped filing.